What is the CVSS score of CVE-2020-16198?

CVE-2020-16198 has a CVSS 3.1 base score of 6.3 (Medium). CVSS vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L. EPSS exploitation probability: 0.6%.

Clinical Collaboration Platform CVE-2020-16198

MEDIUM

Protection Mechanism Failure (CWE-693)

2020-09-18 ics-cert@hq.dhs.gov

Information Disclosure Clinical Collaboration Platform

6.3

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.3 MEDIUM

AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Attack Vector

Adjacent

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

Low

Availability

Low

Lifecycle Timeline

CVE Published

Sep 18, 2020 - 18:15 nvd

MEDIUM 6.3

DescriptionNVD

When an attacker claims to have a given identity,

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.

AnalysisAI

When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct. Rated medium severity (CVSS 6.3), this vulnerability is no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-693. When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct. Affected products include: Philips Clinical Collaboration Platform.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.